Clinical Trials Browser

Phase 2 × Doxorubicin × Tumor-Agnostic × Clear all

NCT03907475 2026-03-18

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

Phase 2 Recruiting

Neoplasm Metastasis

NCT02412670 2023-07-10

Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer

Phase 2 Completed

36 enrolled 14 charts

Carcinoma

NCT01031420 2019-09-17

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Phase 2 Completed

54 enrolled 7 charts

Neoplasms